MedTrace Logo

A Study Comparing Doxycycline and Levofloxacin for Treating COPD Exacerbations

NCT06915688 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 188

Last updated 2025-04-08

No results posted yet for this study

Summary

This study will include patients with chronic obstructive pulmonary disease (COPD) who present with an acute exacerbation. Participants will be randomly assigned to receive either doxycycline or levofloxacin for 5 days. The aim is to compare how effective each antibiotic is in improving symptoms after 2 days of treatment.

Conditions

Interventions

DRUG

Doxycycline

Doxycycline will be given to COPD group 1

DRUG

Levofloxacin

Levofloxacin given to copd patients

Sponsors & Collaborators

  • Amina Aslam

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-15
Primary Completion
2025-07-28
Completion
2025-07-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06915688 on ClinicalTrials.gov